FDA Recall Alert: Compounded Semaglutide, Valsartan, and Clindamycin — September 2026
The FDA reported 23 drug enforcement actions in the two weeks ending September 1, 2026. Three of these affect medications that millions of Americans take: compounded semaglutide injections, brand-name Diovan (valsartan), and clindamycin oral solution. This article covers what was recalled, why, and what you should do if you take any of these drugs.
Compounded Semaglutide Injections — 10 Lots Recalled (Class II)
Apollo Care, LLC of Columbia, Missouri issued Class II recalls for 10 different strengths of compounded semaglutide injectable vials. The recalls cover every strength Apollo Care produces, from 0.9 mg to 20 mg per vial.
The reason is the same across all 10 recalls: the FDA found particulate matter in the vials. Testing identified the particles as nylon, polyamide, and silk or proteinaceous-type material. Particulate matter in an injectable drug can cause blood vessel blockage, inflammation, or immune reactions at the injection site.
Affected Products
| Product | NDC | Recall Number |
|---|---|---|
| Semaglutide 0.9 mg (0.9 mg/mL), 1 mL vial | 71170-810-01 | D-0752-2026 |
| Semaglutide 2.25 mg (0.9 mg/mL), 2.5 mL vial | 71170-811-02 | D-0748-2026 |
| Semaglutide 2.5 mg (1 mg/mL) + Glycine, 2.5 mL vial | 71170-711-02 | D-0753-2026 |
| Semaglutide 4.5 mg (0.9 mg/mL), 5 mL vial | 71170-812-03 | D-0750-2026 |
| Semaglutide 5 mg (1 mg/mL) + Glycine, 5 mL vial | 71170-712-03 | D-0754-2026 |
| Semaglutide 6.75 mg (4.5 mg/mL), 1.5 mL vial | 71170-821-01 | D-0749-2026 |
| Semaglutide 7.5 mg (5 mg/mL) + Glycine, 1.5 mL vial | 71170-721-01 | D-0755-2026 |
| Semaglutide 9 mg (4.5 mg/mL), 2 mL vial | 71170-822-02 | D-0751-2026 |
| Semaglutide 10 mg (5 mg/mL) + Glycine, 2 mL vial | 71170-722-02 | D-0756-2026 |
| Semaglutide 12.5 mg (2.5 mg/mL), 5 mL vial | 71170-495-05 | D-0747-2026 |
| Semaglutide 20 mg (5 mg/mL) + Glycine, 4 mL vial | 71170-724-04 | D-0757-2026 |
All 10 products were distributed nationwide in the United States. These are compounded semaglutide products, not the FDA-approved brand names Ozempic or Wegovy made by Novo Nordisk. Compounded versions are mixed by pharmacies or outsourcing facilities and are not interchangeable with the brand-name products.
What Patients Should Do
If you receive semaglutide injections from a compounding pharmacy, check with your pharmacy to find out if your supply came from Apollo Care (NDC numbers start with 71170). Do not inject any vial that looks cloudy, has visible particles, or appears discolored. Contact your prescriber about switching to a different supply source or to brand-name Ozempic or Wegovy.
Diovan (Valsartan) 160 mg — Novartis Recall (Class II)
Novartis Pharmaceuticals Corporation recalled Diovan (valsartan) 160 mg tablets, 90-count bottles. The tablets failed dissolution specifications, which means the drug may not break down and absorb properly in the body.
A tablet that does not dissolve correctly may deliver too little medication. For valsartan, a blood pressure drug, this could mean your blood pressure stays higher than expected even though you take your medication on schedule.
Affected Product
| Product | Manufacturer | Recall Number |
|---|---|---|
| Diovan (valsartan) 160 mg, 90 tablets | Patheon Manufacturing / Novartis | D-0746-2026 |
Distribution was nationwide in the United States. This recall applies only to the 160 mg strength. Other strengths of Diovan (40 mg, 80 mg, 320 mg) and generic valsartan from other manufacturers are not affected.
What Patients Should Do
If you take brand-name Diovan 160 mg, check your bottle for the Novartis/Patheon labeling and NDC number starting with 0078. Contact your pharmacy to verify your lot number. Your doctor may switch you to generic valsartan or a different strength until Novartis resolves the dissolution issue. Do not stop taking your blood pressure medication without medical advice.
Clindamycin Palmitate HCl Oral Solution — Heritage/Avet Recall (Class II)
Heritage Pharmaceuticals (distributed by Avet Pharmaceuticals) recalled Clindamycin Palmitate Hydrochloride for Oral Solution, 75 mg/5 mL, in 100 mL bottles. The recall is due to the presence of particles and white flakes in the reconstituted bottles.
Clindamycin is a widely prescribed antibiotic used to treat bacterial infections including skin infections, bone infections, and dental infections. The oral solution form is commonly prescribed for children.
Affected Product
| Product | NDC | Recall Number |
|---|---|---|
| Clindamycin Palmitate HCl for Oral Solution, 75 mg/5 mL, 100 mL | 23155-603-51 | D-0768-2026 |
Distribution was nationwide in the United States.
What Patients Should Do
If you or your child takes clindamycin oral solution, check the NDC number on your bottle. If it matches 23155-603-51, look for particles or white flakes in the liquid after you mix it. Contact your pharmacy for a replacement from a different manufacturer. Many other manufacturers produce generic clindamycin oral solution.
Other Recalls Reported (August 18 – September 1, 2026)
The FDA also reported recalls for several products less likely to affect typical prescription drug consumers:
- Sildenafil citrate and tadalafil raw ingredients (Shoolin Pharma Chem) — bulk compounding ingredients recalled for CGMP deviations found during FDA inspection. These are not finished pills. They are raw materials used by compounding pharmacies.
- Cefazolin in dextrose injection (Baxter Healthcare) — a hospital IV antibiotic recalled for particulate matter. This is administered in hospitals, not dispensed at retail pharmacies.
- Optiray (ioversol) imaging contrast (Liebel-Flarsheim) — Class I recall for particulate matter in an injectable imaging agent used during CT scans and other procedures.
- Clear Eyes Maximum Itchy Eye Relief (Prestige Brands) — OTC eye drops recalled for potential sterility issues.
- Kian Pee Wan Capsules (Buy-Herbal) — unapproved supplement sold on eBay that contained undeclared dexamethasone and cyproheptadine.
How to Check Your Medications
Every prescription bottle has a lot number and NDC (National Drug Code) printed on the label. To check if your specific bottle is part of a recall:
- Find the NDC number on your prescription label. It is a 10- or 11-digit number.
- Compare it to the NDC numbers listed in this article.
- Call your pharmacy. They can look up the lot number and confirm whether your supply is affected.
- Visit the FDA Safety Alerts page for the most current list of all active recalls.
This article is for informational purposes only and does not constitute medical advice. Information is current as of September 1, 2026 and is based on data from the openFDA Drug Enforcement API. Consult your healthcare provider for guidance on your specific medications.